CenterviewPartnersLogo

Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Richard Girling
Partner
 
Richard Girling is one of Europe’s leading healthcare bankers with over 30 years of experience. Mr. Girling has advised on many of the largest healthcare transactions in Europe and Asia including: Sanofi-Synthelabo's $73 billion acquisition of Aventis, the $24 billion LBO of Alliance Boots plc, AstraZeneca in its $15 billion acquisition of MedImmune, Mayne Pharma's $2 billion sale to Hospira, Alliance Unichem in its $12 billion merger with Boots, CSL in its acquisition of Aventis Behring, and numerous transactions for Roche including the sale of its Vitamins division to DSM for $2 billion.

Since the creation of the Healthcare practice at Centerview Partners, the Healthcare team has advised on a number of significant transactions including: Alliance Boots on its formation of a strategic partnership with Walgreens and its sale in a two-step $27bn transaction, the $4 billion sale of OSI to Astellas, the $3 billion acquisition of the real estate assets of Atria Senior Living Group by Ventas, the $722 million sale of Facet Biotech to Abbott Labs, the $500 million acquisition of a 46% stake in Stallergenes by Ares Life Sciences and the $112 million acquisition of Baxter’s Multisource injectable pharma business and the $153 million acquisition of a 94.1% interest in Promopharm by Hikma.

Mr. Girling established Merrill Lynch’s European healthcare practice in 1998, and was Global Co-Head of Healthcare investment banking for the last six of those years. Following the acquisition by Bank of America, he was appointed the head of the merged Europe, Middle East and Asia (EMEA) and Asia-Pacific healthcare practices for the combined organization. Mr. Girling joined Merrill Lynch in 1998 from Salomon Brothers, where he worked from 1989 to 1998 and was head of the European Pharmaceutical and Healthcare team.

Mr. Girling is a member of the Development Board, St Anne's College, Oxford University and is actively involved in supporting oncology research projects with Imperial College Trust, London.

Mr. Girling holds a B.A. and M.A. degrees in Biochemistry from Oxford University.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
ChampionX Corporation
Announced: Q2 2024
Value: $8.2 billion
Status: Pending

Exclusive financial advisor to ChampionX on its sale to SLB
View All
CenterviewPartnersLogo
New York

Centerview Partners LLC


31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP


1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax
Paris

Centerview Partners France SCS


51 Avenue Hoche


Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC


1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC


555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax





Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC